In a multicenter observational study of 199 PC patients in Japan, patients heterozygous for UGT1A1 were reported to suffer more severe diarrhea than those with the wild-type genotype when receiving the original dose of FOLFIRINOX [36]. The gene discussed is UGT1A1; the disease is pachyonychia congenita.